Publication | Open Access
Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO
103
Citations
19
References
2014
Year
Cancer ImmunosurveillanceImmunologyBronchial NeoplasmImmune Checkpoint InhibitorImmunomodulationImmune FunctionAstragaloside IvLung CancerImmunotherapyMedicineRadiation OncologyTumor Microenvironment
| Year | Citations | |
|---|---|---|
Page 1
Page 1